Page 324 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 324

302   PART III    Therapeutic Modalities for the Cancer Patient


         acid, vitamin E, selenium, and vitamin D. In veterinary medi-  Implementing a Nutritional Plan for the
         cine these nutrients have not been studied in a prospective or   Oncology Patient
         retrospective fashion. The findings in human meta-analyses
  VetBooks.ir  examining oral supplementation for single nutrients (e.g., ascor-  Nutritional Assessment
         bate, selenium, vitamin E) have been inconclusive or negative
         with regard to protective antineoplastic effects. 282  β-Carotene,   To fully assess the cancer patient, information about body weight,
         the precursor to retinol, currently is thought to be ineffective   the body condition score, and a dietary history are crucial. The
         as an antineoplastic agent, and in some instances has proven   dietary history, before and during treatment, should be obtained
         to  be  harmful in certain  populations (i.e., smoking  popula-  to assess kilocaloric intake appropriately. This information allows
         tions). 283–285  Currently vitamin D status and supplementa-  the practitioner to feed the patient appropriately during hospital-
         tion have been an area of intense epidemiologic investigation   ization and, more importantly, to recognize hypophagic behav-
         because of the relative risks of various neoplastic diseases being   iors, allowing for interventions. A typical diet history should
         higher for individuals with low serum vitamin D. 286–288  Unlike   include the forms of food (wet or dry), amounts fed daily, and
         in humans, vitamin D status in dogs and cats directly depends   treats, human table foods, and additional supplements provided.
         on dietary intake because they cannot convert 7-OH-dehydro-  Serial assessment of body weight is important, particularly
         cholesterol to pre–vitamin D. One would expect that serum   when malnutrition is a consideration. Malnutrition often is asso-
         vitamin D concentrations would not fluctuate tremendously   ciated with cachexia and/or anorexia. Anorexic behavior can be
         in  dogs  fed commercial  dog food. 289  Multiple investigations   deduced from the dietary history and can be treated aggressively
         suggest  that  dogs  with  lymphoma  and  MCT  (but  not  OSA)   with nutritional and/or pharmacologic intervention; however, if
         have lower serum vitamin D levels than healthy, breed- and age-  cachexia is suspected, then alternative treatments can be sought.
         matched dogs, which makes vitamin D status an interesting area   The difficulty in clinically differentiating cachexia from anorexia is
         of investigation. 290,291  Part of the conundrum in dogs is that the   our inability to measure loss of lean versus fat mass. The loss of fat
         serum concentrations are about double normal human values,   mass is typical during anorexia, whereas equal loss of lean and fat
         and it is possible that the supplementation of pet foods ensures   mass suggests cachexia. Although this cannot be deciphered effi-
         adequate  serum  concentrations.  The  lower  limit  of  normal   ciently in veterinary practice, overall weight loss guidelines have
         ranges from 60 to 100 ug/mL. 291  The lack of uniformity in lab-  been offered in the human literature; that is, body weight loss of
         oratory testing, such as methods involving high- performance   5% in 1 month or 10% in 3 months without conscientious diet-
         liquid chromatography versus mass spectroscopy are examples of   ing suggests cancer cachexia. 297  This approach may be difficult in
         differences in methodology and applied reference ranges. 292,293    veterinary species because routine loss and gain of weight may be
         More interestingly, when dogs with serum concentrations of less   seasonal, and the burden of gastrointestinal (GI) parasites poten-
         than 100 ug/mL are supplemented with oral cholecalciferol at   tially confounds weight loss issues. Two body condition scoring
         the safe upper limit established by the National Research Coun-  systems have been adopted as a means of nutritional assessment
         cil, serum 25-OH-cholecalciferol serum concentrations do not   in companion species; however, the 1 to 9 body condition scoring
         increase. 294  This suggests that there may be inherent pathways   system (see Fig. 16.2) is better validated in the literature. 469, 470
         in individuals to eliminate vitamin D from the body which   Modest differences in body condition scoring between dogs and
         may just represent metabolic differences between dogs. These   cats exist because of preferential deposition of body fat along the
         findings further corroborate that serum 25-OH-cholecalciferol   inguinal and abdominal areas in cats, whereas dogs tend to have
         status may be a marker for hepatic and renal cytochrome activ-  no preferential deposition. These differences may justify a muscle
         ity that makes individual dogs more prone to develop cancer   condition scoring system in cats (Table 16.7). 268
         based on each individual dog’s inherited metabolism. Whether   The final component of nutritional assessment consists of a
         this is a direct reflection of dietary intake or a reflection of the   routine physical  examination, complete  blood cell count, and
         biochemical disposition in affected dogs with cancer remains to   chemistry evaluation. Physical exam findings consistent with
         be determined.                                        malnutrition include poor hair coat, chronic GI disturbance,
            In humans obesity has been associated with an increased   seborrhea, lethargy, and pallor. The first signs of chronic nutrient
         risk of many cancers, including breast, prostate, colon, and   deficiency are often manifested in areas of rapid cellular anorexia/
         pancreatic cancers; leukemias; and lymphomas. 270–272  Studies   cachexia syndrome turnover, leading to skin, GI, and hematologic
         examining this association in companion animals are limited.   signs, and should be considered in cases of prolonged anorexia.
         The largest retrospective study in dogs showed no associa-  Chronic malnutrition can result in low hemoglobin and red blood
         tion between body condition and cancer, 260  whereas other   cell counts, in addition to hypoproteinemia and hypoalbumin-
         epidemiologic studies suggest obese cats and dogs may have   emia. Additionally, with the trend toward nontraditional feeding
         a slightly higher rate of neoplastic diseases. 295,296  Two  other   practices, diets may lack sufficient mineral content, including cal-
         investigations revealed a more definitive link between obe-  cium, iron, and copper, resulting in bone and hematologic mani-
         sity in female dogs and mammary carcinoma. 278–280  The risk   festations. Many homemade diets lacking supplementation with
         of mammary carcinoma was greater  in obese spayed dogs in   bone meal can lead to secondary hyperparathyroidism and clini-
         one study, whereas obesity was an increased risk independent   cal osteopenia. 298,299  Clients using nontraditional diets should be
         of spay status in another study. 278,280  Both studies suggested   educated through consultation with a veterinary nutritionist.
         an increased risk when obesity is present at 1 year of age and   In dogs, excess body condition (i.e., obesity) may be more of a
         one suggested that obesity at 1 year before diagnosis also was   concern than malnutrition or deficiency. Treatment of obesity is
         associated with an increased risk. 280  The question of whether   not a priority in many cancer patients, considering the metabolic
         early-onset obesity, much like early spaying, epigenetically pre-  changes that may occur during chemotherapy and the potential
         disposes mammary glands to an altered risk of cancer remains   for treatment-related changes in eating patterns. In one study
         to be addressed.                                      body condition did not change from 6 months before diagnosis to
   319   320   321   322   323   324   325   326   327   328   329